SLAMF7 drives calcific aortic valve disease by stabilizing BMP-2 and activating smad1/5 signaling

Calcific aortic valve disease (CAVD) is a common cardiovascular disorder for which no effective pharmacological therapy is currently available to delay its progression. This study investigated the role and underlying mechanisms of signaling lymphocytic activation molecule family member 7 (SLAMF7) in aortic valve calcification. We found that SLAMF7 was significantly upregulated in calcified human aortic valves and in human aortic valve interstitial cells (hVICs) undergoing osteogenic differentiation. Functionally, SLAMF7 overexpression accelerated the osteogenic phenotypic transformation of hVICs. In vivo, targeted knockdown of SLAMF7 using​ antisense oligonucleotides (ASOs) mitigated aortic valve thickening and calcification in apolipoprotein E-deficient (ApoE −/− ) mice fed a high-cholesterol diet. Mechanistically, SLAMF7 was associated with bone morphogenetic protein 2 (BMP-2), reduced its polyubiquitination, and enhanced its protein stability. Additional experiments implicated SMURF1 in the regulation of BMP-2 protein abundance and showed that SLAMF7 overexpression reduced the association between SMURF1 and BMP-2, suggesting a potential mechanism underlying BMP-2 stabilization. This stabilization activated the downstream BMP-2/Smad1/5 signaling cascade to drive hVIC osteogenesis, an effect reversed by BMP pathway inhibition. In conclusion, this study identifies the SLAMF7/BMP-2/Smad1/5 signaling axis as a key driver of aortic valve calcification. These findings provide novel mechanistic insights into the pathogenesis of this disease and suggest that targeting SLAMF7 may represent a potential therapeutic strategy for the management of CAVD.

Authors

Institutions

Publication Details

Journal
Journal of Cardiothoracic Surgery
Published
2026-11-19
DOI
https://doi.org/10.1186/s13019-026-04842-y
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

SLAMF7 drives calcific aortic valve disease by stabilizing BMP-2 and activating smad1/5 signaling

Xiaoyun Zhang, Shanshan Ding, Hongyu Wu, Xiaowei Shen et al.
Journal of Cardiothoracic Surgery
Cardiac Valve Diseases and Treatments
article

SLAMF7 drives calcific aortic valve disease by stabilizing BMP-2 and activating smad1/5 signaling

Xiaoyun Zhang, Shanshan Ding, Hongyu Wu, Xiaowei Shen, Zhifang Wang
article en

Abstract

Calcific aortic valve disease (CAVD) is a common cardiovascular disorder for which no effective pharmacological therapy is currently available to delay its progression. This study investigated the role and underlying mechanisms of signaling lymphocytic activation molecule family member 7 (SLAMF7) in aortic valve calcification. We found that SLAMF7 was significantly upregulated in calcified human aortic valves and in human aortic valve interstitial cells (hVICs) undergoing osteogenic differentiation. Functionally, SLAMF7 overexpression accelerated the osteogenic phenotypic transformation of hVICs. In vivo, targeted knockdown of SLAMF7 using​ antisense oligonucleotides (ASOs) mitigated aortic valve thickening and calcification in apolipoprotein E-deficient (ApoE −/− ) mice fed a high-cholesterol diet. Mechanistically, SLAMF7 was associated with bone morphogenetic protein 2 (BMP-2), reduced its polyubiquitination, and enhanced its protein stability. Additional experiments implicated SMURF1 in the regulation of BMP-2 protein abundance and showed that SLAMF7 overexpression reduced the association between SMURF1 and BMP-2, suggesting a potential mechanism underlying BMP-2 stabilization. This stabilization activated the downstream BMP-2/Smad1/5 signaling cascade to drive hVIC osteogenesis, an effect reversed by BMP pathway inhibition. In conclusion, this study identifies the SLAMF7/BMP-2/Smad1/5 signaling axis as a key driver of aortic valve calcification. These findings provide novel mechanistic insights into the pathogenesis of this disease and suggest that targeting SLAMF7 may represent a potential therapeutic strategy for the management of CAVD.

Journal of Cardiothoracic Surgery
Ningbo University (CN), Ningbo University Affiliated Hospital (CN), Ningbo First Hospital (CN)
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon